Intravesical administration of Dimethyl sulfoxide(DMSO) for patients with Interstitial cystitis

Intravesical administration of Dimethyl sulfoxide(DMSO) for patients with Interstitial cystitis - Dimethyl sulfoxide(DMSO) for patients with Interstitial cystitis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000027494

Enrollment

Registered

2017-05-25

Start date

2004-07-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Interstitial cystitis

Interventions

Intravesical DMSO administration (50%, 50ml),2weeks every, 8 times

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with interstitial cystitis who did not have enough efficacy by bladder hydrodistention

Exclusion criteria

Exclusion criteria: Patients who did not agree this trial

Design outcomes

Primary

Measure	Time frame
IC symptom score	—

Secondary

Measure	Time frame
Frequency-volume chart	—

Countries

Japan

Contacts

Public ContactAtsushi Otsuka

Hamamatsu University School of Medicine Urology

otsuka@hama-med.ac.jp053-435-2306

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026